Xenon Pharmaceuticals Inc (XENE)
35.71
-1.29
(-3.49%)
USD |
NASDAQ |
Jun 26, 11:32
Xenon Pharmaceuticals Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 9.434M |
| December 31, 2021 | 18.44M |
| December 31, 2020 | 32.17M |
| December 31, 2019 | 6.829M |
| December 31, 2018 | |
| December 31, 2017 | 0.311M |
| Date | Value |
|---|---|
| December 31, 2016 | 1.803M |
| December 31, 2015 | 15.58M |
| December 31, 2014 | 28.37M |
| December 31, 2013 | 27.36M |
| December 31, 2012 | 14.31M |
| December 31, 2011 | 6.918M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
6.829M
Minimum
2019
32.17M
Maximum
2020
16.72M
Average
13.94M
Median
Revenue (Annual) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.2262M |
| ESSA Pharma Inc | -- |